Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

被引：28
|
作者：
Le Berre, Catherine [1 ]
Loeuille, Damien [2 ]
Peyrin-Biroulet, Laurent [3 ]
机构：
[1] Nantes Univ Hosp, Inst Malad Appareil Digestif, Nantes, France
[2] Nancy Univ Lorraine, Dept Rheumatol, Nancy Univ Hosp, Nancy, France
[3] Nancy Univ Lorraine, INSERM, U954, Dept Gastroenterol,Nancy Univ Hosp, Nancy, France
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 17卷 / 04期
关键词：
DISEASE;
D O I：
10.1016/j.cgh.2018.08.017
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：794 / 796
页数：3
相关论文
共 50 条
  • [1] Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy Reply
    Hirten, Robert P.
    Ghosh, Subrata
    Colombel, Jean-Frederic
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (04) : 796 - 797
  • [2] A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib
    Bonastre, Pilar Taberner
    Vicente, Gisela Torres
    Cano-Marron, Manuel
    Abizanda, Eva Sese
    Volta Pardo, Tania Dalila
    Schoenenberger-Arnaiz, Joan Antoni
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (06) : 353 - 355
  • [3] VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS
    Thurston, Theresa
    Moskow, Joshua
    Glassner, Kerri
    Abraham, Bincy
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 : S81 - S81
  • [4] VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS
    Thurston, Theresa
    Moskow, Joshua
    Glassner, Kerri
    Abraham, Bincy
    [J]. GASTROENTEROLOGY, 2023, 164 (04) : S104 - S104
  • [5] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis
    Chang, Hui-Chin
    Gau, Shuo-Yan
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1242 - 1242
  • [6] Combination of vedolizumab and immunomodulators in ulcerative colitis
    Pinton, P.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (12) : 3556 - 3556
  • [7] Dual therapy with vedolizumab and tofacitinib in refractory ulcerative colitis patients - single centre experience
    Kolar, M.
    Kastylova, K.
    Lukas, M.
    Duricova, D.
    Hruba, V.
    Machkova, N.
    Cerna, K.
    Jirsa, J.
    Kubickova, K.
    Vojtechova, G.
    Lukas, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 538 - 538
  • [8] Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis
    Yang, Qinglu
    Chen, Liang
    Feng, Lijin
    Liu, Changqin
    Fang, Leilei
    Liu, Zhanju
    Sun, Xiaomin
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E157 - E158
  • [9] Use of Tofacitinib for the Treatment of Arthritis Associated With Vedolizumab in Ulcerative Colitis
    Rubin, David T.
    Cleveland, Noa Krugliak
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1098 - S1099
  • [10] Treatment of Ulcerative Colitis and Seronegative Inflammatory Spondyloarthritis With Vedolizumab and Tofacitinib
    Lee, Joy A.
    Magavi, Pooja R.
    Konijeti, Gauree G.
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : E146 - E146
12345